Search
 
Search
EN 
  • ES
  • DE
  • ZH
   
  • Company
  • Sustainability
  • Innovation
  • Products and services
  • Investors
  • Careers
  • Media
  • Partners
  • Contact
 

Company

Since 1909, Grifols has worked to improve the health and well-being of people around the world.

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.

Read more
  • Mission and values
  • Divisions
    • Bioscience
      • From donors to patients
      • Plasma journey
    • Diagnostic
    • Hospital
    • Bio Supplies
  • Ethics and compliance
  • Grifols Engineering
    • Engineering
      • Project Management
      • Biotech Processes
      • General Processes
    • Machinery
      • Tailor-made Solutions
      • Pharmaceutical Robotics
      • Standardized Processes
    • Consulting
    • Contact
  • Our history
  • Grifols museum
    • La Casa: where it all began
    • The Plant: people helping people
    • The World: From family business to global company
  • Grifology
    • The Cabinet

Every action we take is motivated by our mission to improve people's lives.

Read more

Our unique and remarkable history combines scientific expertise with a desire to serve patients and society.

Read more

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital, and Bio Supplies.

Read more
 

Sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

Read more
  • Commitment to donors and patients
    • Supporting donors
    • Supporting patients
  • Impact on society
  • Our people
  • The environment
  • Ethical leadership
  • Sustainability Reports

Every action we take is motivated by our mission to improve people's lives.

Read more

As mindful stewards of the environment we are resolved to fight climate change.

Read more

Our sustainable business model is based on innovation, quality, safety and integrity.

Read more
 

Innovation

Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.

Read more
  • Accelerating science
  • Research areas
  • Our Work on COVID-19
  • AMBAR®: Research in Alzheimer’s disease
    • AMBAR® Clinical Program
    • AMBAR® Center
    • AMBAR® in the Media

We support research efforts worldwide to solve pressing public health issues.

Read more

AMBAR®, an innovative procedure for Alzheimer's.

Read more

Our work on COVID-19 

Read more
 
 

Investors

Read more
  • Financials
    • Financial Results
    • Annual accounts
    • CNMV - Companies Search
    • SEC communications
    • Fixed income and credit ratings
    • Average period of payment to suppliers
  • Inside Information
  • Other Relevant Information
  • Relevant events
    up to December 31st, 2019
  • Agenda
  • Press releases
  • Corporate governance
    • Board of Directors
      • Committees
      • Regulations
    • General Shareholders’ Meeting
    • Annual corporate governance report
    • Directors' remuneration report
    • Articles of association
    • Corporate policies
  • Corporate Stewardship Reports
  • Presentations
  • Stock information
    • Stock and share capital
      • Class A shares
      • Class B shares
      • ADR program
        • ADR Level I
        • ADR Level III
    • Dividends
    • Agreements between shareholders
    • Major holders and treasury stock
  • Biotest: voluntary takeover offer |
    Freiwilliges übernahmeangebot
 

Careers

People are at the heart of our business. We are committed to continued investment in training and development.

Read more
  • The Grifols Academy
 

Media

Latest news about the company and contact information for journalists and communication professionals.

Read more
  • Media contacts
  • Newsroom
  • Company Statements
 
 

Contact

Read more
  • International Headquarters
  • Adverse reactions – Pharmacovigilance
Search
Show menu
   
Search
com.grifols.labels.close-menu
Company   Sustainability   Innovation   Products and services Investors   Careers   Media   Partners Contact  
English  
  • Spanish
  • German
  • Chinese

Follow

Search
Back
Company Mission and values Divisions   Ethics and compliance Grifols Engineering   Our history Grifols museum   Grifology  
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Mission and values
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Divisions Bioscience Diagnostic Hospital Bio Supplies
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Ethics and compliance
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Grifols Engineering Engineering Machinery Consulting Contact
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Our history
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Grifols museum La Casa: where it all began The Plant: people helping people The World: From family business to global company
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Grifology The Cabinet
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Sustainability Commitment to donors and patients   Impact on society   Our people The environment Ethical leadership Sustainability Reports
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Commitment to donors and patients Supporting donors Supporting patients
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Impact on society
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Our people
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
The environment
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Ethical leadership
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Sustainability Reports
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Innovation Accelerating science Research areas Our Work on COVID-19 AMBAR®: Research in Alzheimer’s disease  
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Accelerating science
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Research areas
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Our Work on COVID-19
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
AMBAR®: Research in Alzheimer’s disease AMBAR® Clinical Program AMBAR® Center AMBAR® in the Media
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Products and services
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Investors Financials   Inside Information Other Relevant Information Relevant events
up to December 31st, 2019 Agenda Press releases Corporate governance   Corporate Stewardship Reports Presentations Stock information   Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot  
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Financials Financial Results Annual accounts CNMV - Companies Search SEC communications Fixed income and credit ratings Average period of payment to suppliers
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Inside Information
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Other Relevant Information
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Relevant events
up to December 31st, 2019
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Agenda
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Press releases
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Corporate governance Board of Directors General Shareholders’ Meeting Annual corporate governance report Directors' remuneration report Articles of association Corporate policies
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Corporate Stewardship Reports
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Presentations
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Stock information Stock and share capital Dividends Agreements between shareholders Major holders and treasury stock
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Careers The Grifols Academy
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
The Grifols Academy
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Media Media contacts Newsroom   Company Statements
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Media contacts
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Newsroom
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Company Statements
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Partners
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Contact International Headquarters Adverse reactions – Pharmacovigilance
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
International Headquarters
EN  
  • ES
  • DE
  • ZH

Follow

Search
Back
Adverse reactions – Pharmacovigilance
EN  
  • ES
  • DE
  • ZH

Follow

INSIDE INFORMATION

Inside Information

GRIFOLS, S.A. guarantees that the texts published in this page correspond exactly and entirely with the texts sent to the CNMV by the Company or by third parties. All the communications are available in the Web page of the CNMV.
Previous
2021 2020
Next

2021


October 26, 2021
Grifols earns approval for the voluntary public tender offer of Biotest


September 17, 2021
Grifols acquires Tiancheng Pharmaceutical Holding, the largest shareholder of Biotest


September 17, 2021
Presentation of Grifols' investment in Biotest and call details to analysts and investors

2020


June 8, 2020
COVID-19 Impacts


March 27, 2020
Grifols and Shanghai RAAS close their strategic alliance in China


March 25, 2020
Grifols has entered into a formal collaboration with U.S. healthcare agencies to produce a treatment to treat COVID-19

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

Follow

© 2022 Grifols, S.A. All rights reserved worldwide.

ABOUT US

Company

Sustainability

Innovation

Products & services

Investors

Careers

Media

TOP WEBSITES

Grifols Plasma

The Grifols Academy of Plasmapheresis

Grifols Scientific Awards

Grifols Engineering

Grifols Egypt for Plasma Derivatives

Victor Grifols i Lucas Foundation

Probitas Foundation

J.A. Grifols Foundation

HELP

Privacy notices

Cookies policy

Cookie Settings

Terms of use

Contact

Glossary

© 2022 Grifols, S.A. All rights reserved worldwide.

This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.

Are you a healthcare professional?

Yes
No

This website uses its own and third party essential (to remember your settings) and non-essential (to analyse our traffic) cookies. Further information about our use of cookies and the third parties using them can be found in our Cookies Policy.

You can accept all non-essential cookies by clicking the "Accept" button, reject their use by clicking the "Refuse" button or set your preferencies by clicking the "Settings" link.

You can withdraw or change your cookies consent at any time by visiting our Cookies Policy.

Settings

Refuse Accept
 
Close

Grifols, S.A.

Avenida de la Generalitat, 152, 08174

Sant Cugat del Vallès (Barcelona), Spain

Essential cookies

These are strictly necessary for the Site to work as requested. Some examples are activating basic functions such as page navigation and access to secure Site areas or customizing the Site presentation (e.g. language). Without these cookies, the Site would not be able to work properly.

Cookies details

By clicking below you consent to the use of the following non-essential cookies:

Analytic cookies

These allow understanding how visitors interact with the Site by monitoring and analyzing your behavior and with the purpose of improving the Site.

Cookies details

Save settings